Proxy Votes Now

Home › Funds › Lord Abbett › Lord Abbett Health Care Fund

Lord Abbett Health Care Fund (LHCAX) proxy voting record 2025-2026

Fund family: Lord Abbett · Filed by LORD ABBETT SECURITIES TRUST (CIK 898031) · SEC series S000064462

Share classes and tickers: LHCAX (C000208658), LHCCX (C000208659), LHCFX (C000208660), LHCIX (C000208662), LHCOX (C000208661), LHCQX (C000208664), LHCSX (C000208665), LHCTX (C000208667), LHCVX (C000208666)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 617 with, 10 against, 0 abstentions (not counted as with management); 2 items carried no recommendation. Shareholder proposals: 2 FOR, 10 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Lord Abbett as a whole

The same two figures as Lord Abbett’s manager page (20,995 ballot items across 30 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsLord AbbettItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)92.6%56895.8%17,917
Backed environmental and social shareholder proposals at US companiesn/a31.6%373

Where this fund voted differently from most Lord Abbett funds

Each ballot item this fund voted is set against the votes of the other Lord Abbett funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most Lord Abbett funds on all 288 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 71.3% of this fund’s 627 such votes could be given a sector; the other 180 (28.7%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care40892.2%
Industrials1800.0%
Consumer Staples1715.9%
Technology400.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3310
Compensation660
Capital Structure620
Audit-related590
Say-on-Pay560
Corporate Governance527
Other Social Issues32
Shareholder Rights and Defenses30
Extraordinary Transactions20
Environment or Climate11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Eli Lilly and CompanyMay 4, 2026$1M102
Gilead Sciences, Inc.April 30, 2026$443,584153
Guardant Health, Inc.June 17, 2026$354,17050
Natera, Inc.June 11, 2026$332,04080
Thermo Fisher Scientific Inc.May 20, 2026$296,078130
Tarsus Pharmaceuticals, Inc.June 25, 2026$284,97960
Cencora, Inc.March 5, 2026$243,171130
Johnson & JohnsonApril 23, 2026$226,838151

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
May 14, 2026CVS Health CorporationStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalAgainstFor
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalAgainstFor
May 12, 2026IDEXX Laboratories, Inc.Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). Shareholder proposalAgainstFor
April 30, 2026Boston Scientific CorporationStockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." Shareholder proposalAgainstFor

Search this fund’s votes by company

635 ballot items at 61 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Lord Abbett Health Care Fund (LHCAX) voted at 61 shareholder meetings of 59 companies, on 635 ballot items in all. Where management made a recommendation, the fund followed it on 98.4% of the items and voted against it 10 times. Its most frequent area of disagreement was corporate governance (7 of its votes against management). It voted on 12 shareholder proposals. It voted FOR the board's own proposals less often than Lord Abbett's funds as a whole (92.6% against 95.8%). It voted the same way as most Lord Abbett funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Lord Abbett’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.